Cargando…

Indirubin inhibits Wnt/β-catenin signal pathway via promoter demethylation of WIF-1

BACKGROUND: Psoriasis is a common inflammatory skin disease. Abnormal proliferation of keratinocytes is one of the psoriatic histopathological features. Indirubin has an essential effect on the proliferation and activation of keratinocytes; however, in psoriasis, the specific mechanism of action of...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shou Gang, Luo, Guang Pu, Qu, Yong Bin, Chen, Yong Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427955/
https://www.ncbi.nlm.nih.gov/pubmed/32795328
http://dx.doi.org/10.1186/s12906-020-03045-9
_version_ 1783570982771884032
author Liu, Shou Gang
Luo, Guang Pu
Qu, Yong Bin
Chen, Yong Feng
author_facet Liu, Shou Gang
Luo, Guang Pu
Qu, Yong Bin
Chen, Yong Feng
author_sort Liu, Shou Gang
collection PubMed
description BACKGROUND: Psoriasis is a common inflammatory skin disease. Abnormal proliferation of keratinocytes is one of the psoriatic histopathological features. Indirubin has an essential effect on the proliferation and activation of keratinocytes; however, in psoriasis, the specific mechanism of action of indirubin on keratinocytes is unclear. In the present study, we revealed the effects of indirubin on DNA methyltransferase 1 (DNMT1), wnt inhibitory factor 1 (wif-1), and wnt/β-catenin signal pathway, in the meantime, we explored the effects of indirubin on proliferation, cell cycle and the apoptosis of HaCaT cells. METHODS: The expression of DNMT1, wif-1, Frizzled2, Frizzled5, and β-catenin in HaCaT cells treated with different concentrations of indirubin were detected by Western blotting and quantitative real-time polymerase chain reaction (qRT-PCR). The expression levels of DNMT1 and wif-1 were observed after treated with different concentrations of indirubin by enzyme-linked immunosorbent assay (ELISA). The wif-1 promoter methylation status was detected by DNA methylation-specific PCR (MSP). The transcriptional activities of wif-1 and β-catenin were discovered by a luciferase reporter gene system. Cell viability was determined by Cell Counting Kit-8 (CCK8) method. The cell cycle was detected by flow cytometry. The apoptotic cells were surveyed by the apoptosis kit. The expression of Inolucrin, Loricrin, Filaggrin, Keratin 17, and transcriptional activation of transglutaminase 1(TGase1) were detected by Western blotting. RESULTS: Indirubin inhibited the expression of DNMT1 and the methylation of the wif-1 promoter. In the wnt signal pathway, indirubin restored the protein expression of wif-1 and inhibited expression of Frizzled2, Frizzled5, and β-catenin. Besides, indirubin inhibited the proliferation of HaCaT cells, induced apoptosis, and arrest cell cycle. We also reported that indirubin could down-regulate the expression of Involucrin, TGase 1, and keratin 17, but the expression of Filaggrin and Loricrin had no significant effect. CONCLUSION: Our research showed that indirubin promoted the demethylation of wif-1 and suppressed the wnt/β-catenin signal pathway, thereby exerted an anti-proliferative effect. This study reveals the anti-proliferation mechanism of indirubin, which may provide an effective option for the treatment of proliferative diseases.
format Online
Article
Text
id pubmed-7427955
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74279552020-08-17 Indirubin inhibits Wnt/β-catenin signal pathway via promoter demethylation of WIF-1 Liu, Shou Gang Luo, Guang Pu Qu, Yong Bin Chen, Yong Feng BMC Complement Med Ther Research Article BACKGROUND: Psoriasis is a common inflammatory skin disease. Abnormal proliferation of keratinocytes is one of the psoriatic histopathological features. Indirubin has an essential effect on the proliferation and activation of keratinocytes; however, in psoriasis, the specific mechanism of action of indirubin on keratinocytes is unclear. In the present study, we revealed the effects of indirubin on DNA methyltransferase 1 (DNMT1), wnt inhibitory factor 1 (wif-1), and wnt/β-catenin signal pathway, in the meantime, we explored the effects of indirubin on proliferation, cell cycle and the apoptosis of HaCaT cells. METHODS: The expression of DNMT1, wif-1, Frizzled2, Frizzled5, and β-catenin in HaCaT cells treated with different concentrations of indirubin were detected by Western blotting and quantitative real-time polymerase chain reaction (qRT-PCR). The expression levels of DNMT1 and wif-1 were observed after treated with different concentrations of indirubin by enzyme-linked immunosorbent assay (ELISA). The wif-1 promoter methylation status was detected by DNA methylation-specific PCR (MSP). The transcriptional activities of wif-1 and β-catenin were discovered by a luciferase reporter gene system. Cell viability was determined by Cell Counting Kit-8 (CCK8) method. The cell cycle was detected by flow cytometry. The apoptotic cells were surveyed by the apoptosis kit. The expression of Inolucrin, Loricrin, Filaggrin, Keratin 17, and transcriptional activation of transglutaminase 1(TGase1) were detected by Western blotting. RESULTS: Indirubin inhibited the expression of DNMT1 and the methylation of the wif-1 promoter. In the wnt signal pathway, indirubin restored the protein expression of wif-1 and inhibited expression of Frizzled2, Frizzled5, and β-catenin. Besides, indirubin inhibited the proliferation of HaCaT cells, induced apoptosis, and arrest cell cycle. We also reported that indirubin could down-regulate the expression of Involucrin, TGase 1, and keratin 17, but the expression of Filaggrin and Loricrin had no significant effect. CONCLUSION: Our research showed that indirubin promoted the demethylation of wif-1 and suppressed the wnt/β-catenin signal pathway, thereby exerted an anti-proliferative effect. This study reveals the anti-proliferation mechanism of indirubin, which may provide an effective option for the treatment of proliferative diseases. BioMed Central 2020-08-14 /pmc/articles/PMC7427955/ /pubmed/32795328 http://dx.doi.org/10.1186/s12906-020-03045-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Liu, Shou Gang
Luo, Guang Pu
Qu, Yong Bin
Chen, Yong Feng
Indirubin inhibits Wnt/β-catenin signal pathway via promoter demethylation of WIF-1
title Indirubin inhibits Wnt/β-catenin signal pathway via promoter demethylation of WIF-1
title_full Indirubin inhibits Wnt/β-catenin signal pathway via promoter demethylation of WIF-1
title_fullStr Indirubin inhibits Wnt/β-catenin signal pathway via promoter demethylation of WIF-1
title_full_unstemmed Indirubin inhibits Wnt/β-catenin signal pathway via promoter demethylation of WIF-1
title_short Indirubin inhibits Wnt/β-catenin signal pathway via promoter demethylation of WIF-1
title_sort indirubin inhibits wnt/β-catenin signal pathway via promoter demethylation of wif-1
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427955/
https://www.ncbi.nlm.nih.gov/pubmed/32795328
http://dx.doi.org/10.1186/s12906-020-03045-9
work_keys_str_mv AT liushougang indirubininhibitswntbcateninsignalpathwayviapromoterdemethylationofwif1
AT luoguangpu indirubininhibitswntbcateninsignalpathwayviapromoterdemethylationofwif1
AT quyongbin indirubininhibitswntbcateninsignalpathwayviapromoterdemethylationofwif1
AT chenyongfeng indirubininhibitswntbcateninsignalpathwayviapromoterdemethylationofwif1